DOYLESTOWN, Pa. (CBS.MW) - Shares of Quigley were boosted 15 percent after the health products maker said preliminary results from an independent study showed patients took fewer antibiotics when ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Dr. Michael Bauer, Medical Director at ...
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...
The product: Quigley's Cold-Eeze zinc lozenges. The claim: Sucking these upon the onset of a cold will reduce the severity and duration of the cold. Key ingredient: Zinc gluconate glycine. Price: ...
Cold-Eeze maker ProPhase Labs Inc. says it is a defendant in a complaint filed by stockholder and former CEO Guy Quigley. Company founder Quigley lost a takeover battle orchestrated by a group of ...
A dispute with its former founder is hurting ProPhase Lab's balance sheet. © 2025 American City Business Journals. All rights reserved. Use of and/or registration on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results